• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Schwind installs 1,000th laser

Article

Schwind eye-tech-solutions GmbH this month is celebrating the 1,000th installation of its proprietary laser system for refractive surgery (Schwind Aramis 750S).

Kleinostheim, Germany-Schwind eye-tech-solutions GmbH this month is celebrating the 1,000th installation of its proprietary laser system for refractive surgery (Schwind Amaris 750S).

“In reaching the number 1,000, we have achieved yet another milestone in the history of our company. This is a great motivation for us to continue to expand our strong market position,” said Rolf Schwind, the company’s chief executive officer.

The first Schwind laser was delivered to South Korea in 1992. Today, laser systems from Schwind have been installed worldwide, with the exception of the United States.

According to estimates by market research company Market Scope, approximately 4,000 excimer lasers from various manufacturers are in operation for the correction of visual defects in Asia, Australia, Europe, and Central and Latin America. Excluding the U.S. market, Schwind achieved a 34% global market share in laser sales in 2011, according to Market Scope.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.